CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 4 Open-market sale Chief Executive Officer sold 33,031 shares at an average $212.60 ($7,022,524)
- 4 Grant or award Director acquired 147 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP - Novus Biologicals sold 3,117 shares at $215.00 ($670,155)
- 4 Open-market sale Director sold 5,000 shares at $203.67 ($1,018,346)
- 4 Open-market sale SVP - General Counsel sold 5,400 shares at $200.00 ($1,080,000)
- 4 Option exercise President, Diagnostics & Genom acquired 1,667 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 35,000 shares at $203.08 ($7,107,681)
- 4 Grant or award Director acquired 514 shares (grant or award)
- 4 Grant or award Director acquired 514 shares (grant or award)
- 4 Grant or award Director acquired 514 shares (grant or award)
- 4 Grant or award Director acquired 514 shares (grant or award)
- 4 Grant or award Director acquired 514 shares (grant or award)
- 4 Grant or award Director acquired 514 shares (grant or award)
- 4 Grant or award Director acquired 514 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,338 shares (to pay taxes)
- 4 Open-market sale Director sold 5,000 shares at $188.47 ($942,334)
- 4 Open-market sale Director sold 10,000 shares at $187.92 ($1,879,173)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 5,000 shares at $176.94 ($884,675)
Page 16 of 35 · 695 filings